Evidence map›Paper›PMID 33561243›Full record

ArticleG3 (Bethesda, Md.)2021

Genome analysis of Salmonella enterica serovar Typhimurium bacteriophage L, indicator for StySA (StyLT2III) restriction-modification system action.

Julie Zaworski, Colleen McClung, Cristian Ruse, Peter R Weigele, Roger W Hendrix, Ching-Chung Ko, Robert Edgar, Graham F Hatfull, Sherwood R Casjens, Elisabeth A Raleigh

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Microorganisms · 2025
    Article
  3. Article
  4. Hybrid Vigor: Importance of Hybrid λ Phages in Early Insights in Molecular Biology.Microbiology and molecular biology reviews : MMBR · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Julie ZaworskiResearch Department, New England Biolabs, Ipswich, MA 01938-2723, USA.
Colleen McClungResearch Department, New England Biolabs, Ipswich, MA 01938-2723, USA.
Cristian RuseResearch Department, New England Biolabs, Ipswich, MA 01938-2723, USA.
Peter R WeigeleResearch Department, New England Biolabs, Ipswich, MA 01938-2723, USA.
Roger W HendrixDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Ching-Chung KoDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Robert EdgarBioengineering Department, University of Pittsburgh, USA.
Graham F HatfullDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Sherwood R CasjensDivision of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Elisabeth A RaleighResearch Department, New England Biolabs, Ipswich, MA 01938-2723, USA.
New England Biolabs (United States) · USUniversity of Pittsburgh · USUniversity of Utah · US

Funding

DNA packaging and delivery by dsDNA virusesR01GM114817 · NIGMS · UNIVERSITY OF UTAH · PI CASJENS, SHERWOOD R. · 2014 to 2017
$1.5M
NIGMS NIH HHS R01 GM114817
6 · The paper itself

Abstract

Bacteriophage L, a P22-like phage of Salmonella enterica sv Typhimurium LT2, was important for definition of mosaic organization of the lambdoid phage family and for characterization of restriction-modification systems of Salmonella. We report the complete genome sequences of bacteriophage L cI-40 13-am43 and L cII-101; the deduced sequence of wildtype L is 40,633 bp long with a 47.5% GC content. We compare this sequence with those of P22 and ST64T, and predict 72 Coding Sequences, 2 tRNA genes and 14 intergenic rho-independent transcription terminators. The overall genome organization of L agrees with earlier genetic and physical evidence; for example, no secondary immunity region (immI: ant, arc) or known genes for superinfection exclusion (sieA and sieB) are present. Proteomic analysis confirmed identification of virion proteins, along with low levels of assembly intermediates and host cell envelope proteins. The genome of L is 99.9% identical at the nucleotide level to that reported for phage ST64T, despite isolation on different continents ∼35 years apart. DNA modification by the epigenetic regulator Dam is generally incomplete. Dam modification is also selectively missing in one location, corresponding to the P22 phase-variation-sensitive promoter region of the serotype-converting gtrABC operon. The number of sites for SenLTIII (StySA) action may account for stronger restriction of L (13 sites) than of P22 (3 sites).

Indexed as

BacteriophagesSalmonella typhimuriumDNA Restriction-Modification EnzymesProteomicsSerogroupDNA Restriction-Modification Enzymeslambdoid phagemethylation statemosaic genomephage tRNArestriction indicatorvirion composition

Identifiers

PMID33561243
PMCPMC8022706
OpenAlexW3122062678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.